Navigation Links
Orphan Drugs - Global Strategic Business Report
Date:12/4/2013

DUBLIN, December 4, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/9n9pzh/orphan_drugs) has announced the addition of the "Orphan Drugs - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This report analyzes the worldwide markets for Orphan Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Europe, Japan, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 113 companies including many key and niche players such as:

- AbbVie Inc.
- Actelion Pharmaceuticals Ltd.
- Amgen Inc.
- AstraZeneca plc
- Bayer HealthCare AG
- Biogen Idec Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim GmbH
- Celgene Corporation
- CEL-SCI Corporation
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Merck Serono International S.A.
- Novartis AG
- Pfizer Inc.
- Recordati S.p.A.
- Orphan Europe
- Sanofi SA
- Genzyme Corporation.


Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the clien
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Kinex Pharmaceuticals Announced that the U.S. Food and Drug Administration has Granted Orphan Drug Status to KX02 for the Treatment of Gliomas
2. Agility-PSR Wins "Best Contract Research Organization" in the 2013 ROAR Awards at the 4th Annual World Orphan Drug Conference in Geneva
3. CMC Contrast Granted Orphan Drug Designation by the FDA for its Liver Specific MRI Contrast Media CMC-001
4. Lumena Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for LUM001 in Four Rare Liver Diseases
5. FDA Designates MST-188 As An Orphan Drug For Treatment Of Acute Limb Ischemia
6. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
7. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
8. Lumena Pharmaceuticals Receives Orphan Drug Designation from US Food & Drug Administration for LUM001 in Four Rare Liver Diseases
9. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
10. NovelMed Awarded NIH Fast Track SBIR Grant for $1.43 Million to Advance Development of its Anti-Complement Antibody for Orphan Disease
11. Orphan Drugs for Cancer: R&D and Market 2013-2023
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Report Details   ... you trends, R&D progress, and predicted revenues ,Where is ... are the commercial prospects for this market and related ... and other trends to 2025, discussing data, opportunities and ... assess regenerative medicine : cell-based therapies that aim ...
(Date:2/27/2015)... Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... fourth quarter and full year ended December 31, 2014. ... PTC. We are now a growing commercial-stage biopharma company, ... rare disease space," stated Stuart W. Peltz, Ph.D., Chief ... bring the first treatment for Duchenne muscular dystrophy to ...
(Date:2/27/2015)... -- Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... Bionik Laboratories, Inc., a Toronto ... accredited investors of units consisting of its common stock ... million. Shares of the Company,s common stock will continue ... symbol "DWTPD" until FINRA,s approval of the ticker "BNKL." ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3
... Fla., Dec. 9, 2011  Breckenridge Pharmaceutical, Inc. ... final approval for their Abbreviated New Drug Application (ANDA) ... are AB rated to Pamine®, a prescription medicine that ... peptic ulcers. Pamine® is marketed by Kenwood Therapeutics. The ...
...  Thoratec (NASDAQ: THOR), a world leader in device-based mechanical ... hearts, said today it will be participating in the ... December 13. Taylor C. Harris, Senior Director ... update on the company, beginning at 10:15 a.m., Eastern ...
Cached Medicine Technology:
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax accounting ... consulting services in addition to a variety of other ... planning. Company finances are a complicated matter that should ... this, complex Canadian tax laws can make it even ... Mew and Company works to advise their clients on ...
(Date:2/28/2015)... Indosoft Inc , developers of ... are pleased to announce the development of Q-Suite 5.9. ... versions of Q-Suite, this new version will include enhancements ... new features to the leading edge call center software. ... will add features to enhance security and protection. Administrators ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will be on ... Show, an annual, premier sustainable building event in Tokyo, ... manufacturers of the latest building products, services and technology. ... manufactured by Pioneer Millworks from their Oregon and New ... hotels, retailers, and corporate offices. Nichibi Global , ...
(Date:2/28/2015)... Pismo Beach, CA (PRWEB) February 28, 2015 ... the needs of Central Coast area residents, recently announced ... Whitening System. It’s a treatment option for new ... patients kick off 2015 with a bright, white smile, ... the discounted price of $299, marked down from the ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2
... Oct. 2 - Flatulence isn,t much fun,for the person having it - or those nearby. ... For,example:, -- Slow down your eating: A little ... everything you swallow. To reduce the amount of air, eat and ... -- Avoid airy drinks and foods: Air also gets into ...
... Patients who undergo liver transplantation at age 60 ... similar to those of younger patients and they ... published in a new study in the October ... John Wiley & Sons. The article is also ...
... John Cousins,President of Biomoda, Inc. (OTC Bulletin Board: ... before the,New Mexico State Legislature,s Interim Tobacco Settlement ... for funding a clinical,study using the company,s assay ... Mexico legislature last year appropriated $350,000 to fund ...
... N.Y., Oct. 2 Suzanne Somers, New York,Times ... Long Island,s most,brilliant, wellness oriented doctors will share ... Expo (Nutrition, Aesthetics, Vitality,Efficacy, Life ... NAVEL ... ... weight loss, beauty, fitness, longevity, vitality and,lifetime wellness. ...
... President to Sign the Bill, CHICAGO, Oct. ... the approval by both congressional chambers of the ... many beneficial dental provisions. The bill now heads ... care, especially for children, is one of the ...
... would ... health IT system, CLEVELAND, Oct. 2 Sidney Taurel, ... LLY ), in a speech,today at the Cleveland Clinic, called ... actively collaborate on a health,information technology system that would provide ...
Cached Medicine News:Health News:Fighting the Gassy Effects of Good Eating, From the Harvard Health Letter 2Health News:Patients over age 60 do well after liver transplantation 2Health News:Biomoda President Testifies Before New Mexico Legislature Supporting Clinical Funding for Early Lung Cancer 2Health News:Healthy Weight Loss Begins With What You Permit to Enter Your Mind, More So Than Even Your Mouth! 2Health News:AGD Applauds Congressional Support of SCHIP Reauthorization 2Health News:Lilly's CEO Calls for Reform of Nation's Drug Safety System 2Health News:Lilly's CEO Calls for Reform of Nation's Drug Safety System 3
... scotopic sensitivity (threshold) testing provides clinically ... of ophthalmic conditions. Dark adaptometry is ... of retinal degenerations, senile miosis, high ... blinding conditions, while whole-field scotopic sensitivity ...
... Inc.s EPIC-4000 offers fast and easy ERG, ... compact, modular package. It provides ERG stimulus ... the International Standard for the Clinical Electrophysiology ... including the pattern ERG, allow a variety ...
... 3 will enable eye care professionals to ... improved ultrasound technology. The PACHETT 3 uses ... used in all the DGH pachymeters used ... Model 555 PACHETTE 3 is capable of ...
The Medmont C100 Colour Vision Tester is an electronic colour vision screening device which is used to rapidly detect red/green colour vision deficiencies. Its high sensitivity provides a positive in...
Medicine Products: